Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials

Jing Wang, Li Yu, Kefeng Li
doi: https://doi.org/10.1101/2020.04.13.20064295

Article usage

Article usage: April 2020 to November 2024

AbstractFullPdf
Apr 20201281802426
May 202019060668
Jun 20205070148
Jul 20203430120
Aug 2020187097
Sep 2020166065
Oct 2020118031
Nov 202093033
Dec 2020122222
Jan 202165615
Feb 202178722
Mar 202183616
Apr 202197820
May 202198619
Jun 202198937
Jul 202153546
Aug 2021512113
Sep 202143124
Oct 202162439
Nov 202154426
Dec 202168310
Jan 202241410
Feb 202249523
Mar 202248121
Apr 20224766
May 20223337
Jun 20223621
Jul 20222722
Aug 20222656
Sep 20224149
Oct 20221905
Nov 20221902
Dec 20221514
Jan 20232123
Feb 20231245
Mar 20233022
Apr 202320213
May 202325210
Jun 20231346
Jul 20231105
Aug 202324135
Sep 20232468
Oct 20231715
Nov 202329123
Dec 20231338
Jan 2024929
Feb 2024902
Mar 20241333
Apr 202456415
May 20241210
Jun 20241457
Jul 202454611
Aug 20241217
Sep 202416810
Oct 2024121016
Nov 2024805
Back to top
Posted April 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Jing Wang, Li Yu, Kefeng Li
medRxiv 2020.04.13.20064295; doi: https://doi.org/10.1101/2020.04.13.20064295
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area